top of page

Dr. Richard Mclean

Weizmann institute

My primary interest lies at the blurry line between metabolism and abiotic organic chemistry and using enzyme engineering to expand that overlap as much as possible. I completed my doctoral work on the Hydroxypropionyl-CoA/Acrylyl-CoA (HOPAC) Cycle in the Erb Lab at the Max Planck Institute for Terrestrial Microbiology in 2022 and joined the Fleishman Lab at the Weizmann Institute of Science as a postdoctoral fellow in 2023. Within the W-BioCat consortium, my project will center on improving the expressibility of the Pyrococcus furiosus Wco biosynthetic pathway in E. coli, and further work with the Wco-containing aldehyde oxidoreductases.

Dr. Richard Mclean
bottom of page